| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $850.00K | $0.00 | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $72.84M | $57.48M | $50.36M | $41.66M | $81.88M |
| R&D | $55.97M | $42.34M | $38.12M | $30.00M | $20.34M |
| SG&A | $16.87M | $15.13M | $12.24M | $11.66M | $10.93M |
| Operating Income | -$72.84M | -$56.63M | -$50.36M | -$41.66M | -$81.88M |
| Interest Expense | – | – | – | $0.00 | $370.00K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$66.49M | -$49.38M | -$42.49M | -$39.23M | -$82.18M |
| EPS (basic) | -0.4200 | -0.3600 | -0.3300 | -0.3700 | -1.3100 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | $137.40M | – | – | – |